Abstract: Schistomiasis is one of the major public health problems, and for more than two decades Praziquntel (PZQ) has remained the drug of choice for its treatment. However, studies proved that reliance on one drug raised the concern of development of tolerance or even resistance. The present work aimed at studying the effect of different schedules of the flukicidal drug triclabendazole (TCBZ), in a dose of 120mg/kg body weight, on Schistoma mansoni worm load, female fecundity and egg deposition in liver and intestine of infected mice, and at studying its biochemical toxic effects on some liver enzymes activities.The present findings indicated that the administration of TCBZ to mice infected with Egyptian S.mansoni strain was not effective except when the drug was given after the start of egg shedding in the stools. However, the antischitosomal effect was moderate as the results showed 50% reduction in worm burden and around 40% reduction in liver and intestinal egg loads. On the other hand, the impact on oogram pattern was not clear except regarding the percentage of dead ova which was much higher than the corresponding control. As regards the biochemical parameters studied, no change in the activity of all tested enzymes was observed. However, animals which received two doses of the drug after the start of egg shedding exhibited 24% reduction in alanine transaminase (ALT) activity. In conclusion, our results indicated that, still, there is no alternative to prazquantel and there is an urgent need for discovery of new antischistosomal drugs. In addition studying different combinations and schedules of the already available drugs as artemether and TCBZ is recommended.
INTRODUCTION
Schistosomiasis is one of the major public health threats. More than 600 million people worldwide are at risk of infection, and close to 200 million are actually infected. (1) Chronic morbidity is the major impact of schistosomiasis on ill health. This is due to repeated infection and development of non-fatal but debilitating sequelae, ranging from subtle to severe morbidity specific to schistosomiasis as hepatic fibrosis and urinary obstructions (2) . Schistosoma japonicum. Usually PZQ chemotherapy of S.mansoni using the standard dose of 40 mg/kg body weight (3, 4) .
results in cure rates of more than 70% and mean egg count reduction rates of more than 95%, after six to twelve weeks post treatment.
However, interestingly and unexpectedly, low cure rates have been reported from Northern Senegal. Initial studies there demonstrated a cure rate of only 18%. Also, in Egypt cure rates lower than normal were recorded from S.mansoni infected patients who were treated with the recommended single oral dose of PZQ. (5, 6) Thus, reliance on a single drug has raised considerable concern that tolerance or even resistance to the drug might develop and there are a continuing need for new antischistosomal drugs (5, 7) . This spectrum of activity suggests a mechanism of action unlike that of other benzimidazole anti-helminthics (8) (9) (10) .
When TCBZ was tested against S.mansoni in mice, controversial results were reported. Khalil (2000) and El-Sayad , worm reduction ranged between 84% and 87%. Male worms were more susceptible to the drug than females. TCBZ induced cessation of egg laying. Also, the drug had no prolonged toxic effect on hepatocytes and was expected to be useful in treatment of human schistosomiasis (11, 12) .
In contrast, Keiser et al., (2006) reported that with the administration of TCBZ in a single oral dose of 120 mg/kg, 3 days before infection of mice with S.mansoni or double doses of 120 mg/kg 7 weeks after infection, the drug failed to significantly reduce intestinal tissue egg loads and eggs of all developmental stages were observed. They concluded that TCBZ displays weak and inconsistent antischistosomal activity (13) .
In view of the facts that there is an urgent need for schistosomicidal drugs rather than praziquantel and that TCBZ in the tested schedules gave inconsistent results, while it proved to be effective against both mature and immature Fasciola hepatica. Thus, this study was designed to test the efficacy of TCBZ on different stages of maturation of S.mansoni worms.
Also, to study the biochemical toxic effects of TCBZ on some serum enzymes activities in mice infected with S.mansoni . It was used as control for biochemical tests.
MATERIAL AND METHODS

Drugs :
Triclabendazole: a benzimidazole derivative (Fasinex suspension) was obtained from a local pharmacy.
Dose: 120 mg/kg body weight (11) .
Praziquantel (Distocide suspension) was provided by Ministry of Health and
Population (MOH & P) .
Dose: 600 mg/kg body weight (14) .
Drugs were administered orally using a stomach tube . mice (15) .
* Perfusion of mice. Mice were killed by cervical dislocation after two weeks from the last treatment. Worms were recovered from the hepatic and portomesenteric vessels using the perfusion technique (16) .
Worms were counted and sex was and digesting it overnight in 5 ml KOH (5%). After complete digestion, the samples were vortexed and 3 aliquotes of 100 l each were examined microscopically and ova were counted (20) .
II Biochemical study
Serum alkaline phosphatase activity 
RESULTS
The results obtained in different groups
were compared with those of the corresponding control groups as shown in The male to female worm ratio was higher Furthermore, eggs collected from fecal samples of treated mice were able to hatch and develop active miracidia. (13) The present findings indicate that the administration of TCBZ to mice infected with Egyptian S.mansoni strain was not effective except when the drug was given after the start of egg shedding in the stools.
However, the antibilharzial effect was moderate as the results showed 50% reduction in worm burden and around 40% reduction in liver and intestinal egg load.
On the other hand, the impact on oogram pattern was not clear except regarding the percentage of dead ova which showed clear reduction when compared to the corresponding control.
In contrast to our findings Khalil (2000) who used the same S. mansoni strain reported excellent antischistosomal effect.
She reported a total worm reduction of 93.0 ± 6.4
9.6 ± 0.9 9.6 ± 0.9
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